
Vera Therapeutics
Biotechnology company developing innovative biologic therapeutics
Stránky společnostiRok založení
2016
O společnosti
Total Funding
$188.9M
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.
Number of employees
11-50
Headquarters
San Francisco, California, United States